BNBX
Applied DNA Sciences, Inc.
NASDAQ: BNBX · FINANCIAL SERVICES · ASSET MANAGEMENT
$0.53
+3.91% today
Updated 2026-04-30
Market cap
$2.93M
P/E ratio
0.00
P/S ratio
1.60x
EPS (TTM)
$282.39
Dividend yield
—
52W range
$0 – $14
Volume
1.0M
Applied DNA Sciences, Inc. (BNBX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,249.00%
ROE
-199.10%
ROA
-98.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $9.03M | $-14.29M | 49.66% | -147.86% | -158.25% |
| 2022 | $18.17M | $-8.27M | 27.82% | -76.89% | -45.51% |
| 2023 | $13.37M | $-9.95M | 41.39% | -81.94% | -74.41% |
| 2024 | $3.43M | $-6.99M | 29.63% | -408.72% | -203.78% |
| 2025 | $2.14M | $-15.16M | 39.26% | -750.92% | -709.46% |